Lazard Asset Management LLC Zai Lab LTD Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$27.77 - $64.4 $1.84 Million - $4.27 Million
-66,339 Closed
0 $0
Q4 2021

Feb 09, 2022
SELL
$54.9 - $105.21 $1.71 Million - $3.27 Million
-31,101 Reduced 31.92%
66,339 $4.17 Million
Q3 2021

Nov 15, 2021
BUY
$105.0 - $178.37 $9.68 Million - $16.4 Million
92,177 Added 1751.42%
97,440 $10.3 Million
Q2 2021

Aug 12, 2021
BUY
$125.11 - $180.0 $658,453 - $947,340
5,263 New
5,263 $931,000

Others Institutions Holding ZLAB

# of Institutions
121
Shares Held
46.7M
Call Options Held
223K
Put Options Held
588K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.66B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email